Published in Lancet on October 15, 1988
THE MEASUREMENT OF SYMPATHETIC VASOCONSTRICTOR ACTIVITY IN THE LOWER EXTREMITIES. J Clin Invest (1930) 32.02
Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization. J Biol Chem (1983) 9.32
A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis. Cell (1991) 6.14
The heat resistance of bacterial spores at various water activities. J Gen Microbiol (1966) 4.23
Differential localization of two myosins within nematode thick filaments. Cell (1983) 3.84
Assessment of inactivated influenza-A vaccine after three outbreaks of influenza A at Christ's Hospital. Lancet (1979) 3.55
Asbestos hazards in naval dockyards. Ann Occup Hyg (1968) 3.46
Creating a population-based linked health database: a new resource for health services research. Can J Public Health (1998) 3.05
Outbreak of Salmonella napoli infection caused by contaminated chocolate bars. Lancet (1983) 2.82
Cellular transformation by coordinated action of three peptide growth factors from human platelets. Nature (1984) 2.66
A freely diffusible form of Sonic hedgehog mediates long-range signalling. Nature (2001) 2.50
Worldwide esophageal cancer collaboration. Dis Esophagus (2009) 2.41
Transforming growth factor-beta controls receptor levels for epidermal growth factor in NRK fibroblasts. Cell (1984) 2.30
Mithramycin inhibits SP1 binding and selectively inhibits transcriptional activity of the dihydrofolate reductase gene in vitro and in vivo. J Clin Invest (1991) 2.28
Studies on the "insoluble" glycoprotein complex from human colon. Identification of reduction-insensitive MUC2 oligomers and C-terminal cleavage. J Biol Chem (1999) 2.11
Rates of ligand binding to periplasmic proteins involved in bacterial transport and chemotaxis. J Biol Chem (1983) 2.06
Antiproliferative activity of G-rich oligonucleotides correlates with protein binding. J Biol Chem (1999) 2.05
MUC5B is a major gel-forming, oligomeric mucin from human salivary gland, respiratory tract and endocervix: identification of glycoforms and C-terminal cleavage. Biochem J (1998) 2.05
Influenza at Christ's Hospital: March, 1974. Lancet (1976) 1.96
Post dural puncture headache. Anaesthesia (2003) 1.94
Different mucins are produced by the surface epithelium and the submucosa in human trachea: identification of MUC5AC as a major mucin from the goblet cells. Biochem J (1996) 1.94
Pre-anaesthesia assessment clinics. Anaesthesia (2000) 1.85
Immunological identification of the genes encoding the four myosin heavy chain isoforms of Caenorhabditis elegans. Proc Natl Acad Sci U S A (1986) 1.84
STUDIES ON THE ACTIVITY OF THE LUMBAR SYMPATHETIC NERVOUS SYSTEM. Ann Surg (1930) 1.83
Antibiotic resistance of Shigella sonnei. Lancet (1970) 1.83
Structural analysis of alpha-enolase. Mapping the functional domains involved in down-regulation of the c-myc protooncogene. J Biol Chem (2000) 1.80
Further studies on the antibiotic resistance of Shigella sonnei. I. Transferable antibiotic resistance. J Hyg (Lond) (1968) 1.78
Controlled trial of inactivated influenza vaccine containing the a-Hong Kong strain during an outbreak of influenza due to the a-England-42-72 strain. Lancet (1973) 1.77
Natural infection with influenza A (H3N2). The development, persistance and effect of antibodies to the surface antigens. J Hyg (Lond) (1976) 1.77
The Groucho-like transcription factor UNC-37 functions with the neural specificity gene unc-4 to govern motor neuron identity in C. elegans. Development (1997) 1.77
Myosin and paramyosin are organized about a newly identified core structure. J Cell Biol (1985) 1.76
Mucus glycoproteins from 'normal' human tracheobronchial secretion. Biochem J (1990) 1.66
Targeted disruption of the murine Nhe1 locus induces ataxia, growth retardation, and seizures. Am J Physiol (1999) 1.66
MUC5AC, but not MUC2, is a prominent mucin in respiratory secretions. Glycoconj J (1996) 1.66
PUBLIC HEALTH ENGINEERING: SURVEY OF CONNECTICUT'S SHORE BATHING WATERS. Am J Public Health Nations Health (1932) 1.64
Active conformation of the globin genes in uninduced and induced mouse erythroleukemia cells. Cell (1978) 1.64
CHANGES IN THE VASOMOTOR REACTION ASSOCIATED WITH GLOMUS TUMORS. J Clin Invest (1937) 1.57
Muscular dystrophy in a litter of golden retriever dogs. Muscle Nerve (1988) 1.57
Mithramycin blocks protein binding and function of the SV40 early promoter. J Clin Invest (1989) 1.53
A study of poliovaccination in infancy: excretion following challenge with live virus by children given killed or living poliovaccine. J Hyg (Lond) (1966) 1.51
Dynamic dead space in face masks used with noninvasive ventilators: a lung model study. Eur Respir J (2004) 1.51
UNC-4/UNC-37-dependent repression of motor neuron-specific genes controls synaptic choice in Caenorhabditis elegans. Genes Dev (1999) 1.50
Results of conservative management of cervical intraepithelial neoplasia. Obstet Gynecol (1992) 1.49
Cloning and characterization of a human c-myc promoter-binding protein. Mol Cell Biol (1991) 1.47
Identification of myosin heavy chain in Saccharomyces cerevisiae. Nature (1985) 1.47
Percutaneous transthoracic needle aspiration biopsy: a comprehensive review of its current role in the diagnosis and treatment of lung tumors. Chest (1998) 1.42
The Caenorhabditis elegans gene T23G5.5 encodes an antidepressant- and cocaine-sensitive dopamine transporter. Mol Pharmacol (1998) 1.41
Effects of various gases on the survival of dried bacteria during storage. Appl Microbiol (1973) 1.40
Vaccinial vulvo-vaginitis. J Obstet Gynaecol Br Commonw (1967) 1.39
Further studies on the antibiotic resistance of Shigella sonnei. II. The acquisition of transferable antibiotic resistance in vivo. J Hyg (Lond) (1968) 1.38
Mithramycin blocks transcriptional initiation of the c-myc P1 and P2 promoters. Biochemistry (1991) 1.38
Localization and enhanced current density of the Kv4.2 potassium channel by interaction with the actin-binding protein filamin. J Neurosci (2000) 1.35
'Soluble' and 'insoluble' mucins--identification of distinct populations. Biochem Soc Trans (1995) 1.34
Radiological survey of men exposed to asbestos in naval dockyards. Br J Ind Med (1972) 1.33
Inhibition of DNA replication and induction of S phase cell cycle arrest by G-rich oligonucleotides. J Biol Chem (2001) 1.32
Metastatic cystosarcoma phyllodes: a case report and review of the literature. J Surg Oncol (1972) 1.30
Studies on Hg(II)-induced H2O2 formation and oxidative stress in vivo and in vitro in rat kidney mitochondria. Biochem Pharmacol (1993) 1.25
The kinetics of selective biological transport. IV. Assessment of three carrier systems using the erythrocyte-monosaccharide transport data. Biophys J (1968) 1.25
Likelihood of malignancy in a solitary pulmonary nodule: comparison of Bayesian analysis and results of FDG-PET scan. Chest (1997) 1.25
The mechanism of sugar binding to the periplasmic receptor for galactose chemotaxis and transport in Escherichia coli. J Biol Chem (1980) 1.25
Acute hepatic dysfunction following parenteral amiodarone administration. Postgrad Med J (1989) 1.24
Can the Sino-nasal Outcome Test (SNOT-22) be used as a reliable outcome measure for successful septal surgery? Clin Otolaryngol Allied Sci (2003) 1.24
The kinetics of selective biological transport. 3. Erythrocyte-monosaccharide transport data. Biophys J (1968) 1.23
Recent developments in the assessment of quality of life in multiple sclerosis (MS). Mult Scler (1999) 1.23
Inhibition of cytomegalovirus in vitro and in vivo by the experimental immunosuppressive agent leflunomide. Intervirology (1999) 1.23
Regulation of neurotransmitter vesicles by the homeodomain protein UNC-4 and its transcriptional corepressor UNC-37/groucho in Caenorhabditis elegans cholinergic motor neurons. J Neurosci (2001) 1.19
Resolution and properties of a protein kinase catalyzing the phosphorylation of a wheat germ cytokinin-binding protein. Plant Physiol (1983) 1.19
Changing attitudes to the diagnosis of asbestos disease. J R Nav Med Serv (1970) 1.18
Triple helix formation by purine-rich oligonucleotides targeted to the human dihydrofolate reductase promoter. Nucleic Acids Res (1992) 1.17
Influenza A: infection and reinfection. J Hyg (Lond) (1984) 1.16
Fetal growth retardation in rats from different levels of hypoxia. Biol Neonate (1986) 1.16
Infection with influenza A H1N1. 1. Production and persistence of antibody. J Hyg (Lond) (1986) 1.14
1-Phenyl-5-pyrazolyl ureas: potent and selective p38 kinase inhibitors. Bioorg Med Chem Lett (2000) 1.14
Phase I trial of the murine monoclonal anti-GD2 antibody 14G2a in metastatic melanoma. Cancer Res (1992) 1.12
Infection with influenza A H1N1. 2. The effect of past experience on natural challenge. J Hyg (Lond) (1986) 1.11
Mucus glycoproteins from pig gastric mucosa: identification ofdifferent mucin populations from the surface epithelium. Biochem J (1997) 1.08
UK Naval Dockyards asbestosis study: survey of the sample population aged 50-59 years. Br J Ind Med (1979) 1.08
Preliminary observations on the therapy of the myeloid blast phase of chronic granulocytic leukemia with plicamycin and hydroxyurea. N Engl J Med (1986) 1.08
A false compatibility. Anaesthesia (1991) 1.08
Ion metabolism in a halophilic blue-green alga, Aphanothece halophytica. Arch Microbiol (1976) 1.07
International outbreak of staphylococcal food poisoning caused by contaminated lasagne. J Hyg (Lond) (1986) 1.07
Inhibition of superoxide and ferritin-dependent lipid peroxidation by ceruloplasmin. J Biol Chem (1989) 1.07
Novel mechanism of inhibition of cytomegalovirus by the experimental immunosuppressive agent leflunomide. Transplantation (1999) 1.06
Inhibition of transcription of the human c-myc protooncogene by intermolecular triplex. Biochemistry (1998) 1.06
Peritoneal implantation of squamous cell carcinoma following rupture of a dermoid cyst during laparoscopic removal. Gynecol Oncol (2002) 1.06
The kinetics of selective biological transport. II. Equations for induced uphill transport of sugars in human erythrocytes. Biophys J (1965) 1.05
Accelerated cytomegalovirus retinitis secondary to immunosuppressive therapy. Arch Ophthalmol (1986) 1.05
Epidermal growth factor secreted from the salivary gland is necessary for liver regeneration. Am J Physiol (1995) 1.05
Potentiation of acetazolamide induced ectrodactyly in SWV and C57BL/6J mice by cadmium sulfate. Teratology (1984) 1.05
Viral inhibition of interferon signal transduction. Intervirology (1999) 1.04
Properties of a calmodulin-activated Ca2+-dependent protein kinase from wheat germ. Biochim Biophys Acta (1983) 1.04
Ocular complications of Tangier disease. Am J Med (1987) 1.04
Macromolecular organization of saliva: identification of 'insoluble' MUC5B assemblies and non-mucin proteins in the gel phase. Biochem J (2000) 1.03
Triplex formation prevents Sp1 binding to the dihydrofolate reductase promoter. J Biol Chem (1992) 1.03
What constitutes general surgical training? Evidence from the log books of trainees in one district general hospital. Ann R Coll Surg Engl (1994) 1.03
Influenza B at Christ's Hospital: natural antibody to influenza B estimated by radial haemolysis. J Hyg (Lond) (1981) 1.03
Salivary proteins promote proteolytic activity in Streptococcus mitis biovar 2 and Streptococcus mutans. Mol Oral Microbiol (2012) 1.03
Factors that influence the employment status of people with multiple sclerosis: a multi-national study. J Neurol (2009) 1.03
Evidence for oral excretion of E.B. virus in infectious mononucleosis. Lancet (1972) 1.02
Distribution of nitric oxide synthase containing neurons in the rectal myenteric plexus and anal canal. Morphologic evidence that nitric oxide mediates the rectoanal inhibitory reflex. Dis Colon Rectum (1994) 1.02